Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

214526 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-04

Study Completion Date

2025-01-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Electronic Health Record Strategies to Promote Diverse Participation in Research

NCT05348603

Patient Participation

COMPLETED NA

Using Multimedia Patient Feedback to Reduce Disparities in VA Healthcare

NCT00914485

Primary Care

COMPLETED NA

Using IT to Improve Access, Communication and Asthma in African American and Hispanic/Latino Adults

NCT02086565

Asthma Communication

COMPLETED NA

Development and Evaluation of an Electronic Health Record-based Medication Complete Communication (EMC2) Strategy

NCT03652272

Medication Adherence

COMPLETED NA

Feasibility of a Clinician Training Program to Improve Patient-provider Communication in the Presence of Health IT Systems in the Exam Room

NCT02915068

Asthma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of the optimization study is to examine the effectiveness on increasing interest in research of an optimized letter versus a generic letter; an optimized message versus a generic message; and an optimized letter and an optimized message versus a generic letter and a generic message.

The secondary objective of the optimization study is to examine the effectiveness on increasing participation in research of an optimized letter versus a generic letter, an optimized message versus a generic message, an optimized letter and an optimized message versus a generic letter and a generic message.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patient Participation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Optimized Letter

Participants receive an 'optimized' letter.

Group Type EXPERIMENTAL

Optimized Letter

Intervention Type OTHER

Patients receive an optimized letter.

Optimized Message

Participants receive an 'optimized' message.

Group Type EXPERIMENTAL

Direct to Patient Message - Optimized

Intervention Type OTHER

Patients receive an optimized direct to patient message via the portal.

Optimized Letter + Optimized Message

Participants receive both a 'optimized' letter and a 'optimized' message.

Group Type EXPERIMENTAL

Optimized Letter

Intervention Type OTHER

Patients receive an optimized letter.

Direct to Patient Message - Optimized

Intervention Type OTHER

Patients receive an optimized direct to patient message via the portal.

Generic Letter

Participants receive a 'usual' letter.

Group Type ACTIVE_COMPARATOR

Traditional Letter

Intervention Type OTHER

Patients receive a traditional letter.

Generic Message

Participants receive a 'usual' message.

Group Type ACTIVE_COMPARATOR

Direct to Patient Message

Intervention Type OTHER

Patients receive a direct to patient message via the portal.

Generic Letter + Generic Message

Participants receive both a 'usual' letter and a 'usual' message.

Group Type EXPERIMENTAL

Traditional Letter

Intervention Type OTHER

Patients receive a traditional letter.

Direct to Patient Message

Intervention Type OTHER

Patients receive a direct to patient message via the portal.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traditional Letter

Patients receive a traditional letter.

Intervention Type OTHER

Direct to Patient Message

Patients receive a direct to patient message via the portal.

Intervention Type OTHER

Optimized Letter

Patients receive an optimized letter.

Intervention Type OTHER

Direct to Patient Message - Optimized

Patients receive an optimized direct to patient message via the portal.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has an account with the online patient portal
* Has logged into the online patient portal at least once in the past year
* Has not set up a research profile